Beta-blocker tolerability in elderly heart failure patients.
Beta-blocker therapy is well established for patients with chronic heart failure. In clinical practice, questions of tolerability and recommended target dose therapy remain important topics.
Düngen
Hans-Dirk
HD
Mehrhof
Felix
F
Apostolović
Svetlana
S
Inkrot
Simone
S
Dietz
Rainer
R
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic / Q000379:methods; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans
D000319:Adrenergic beta-Antagonists